Consolidated Investment Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,100
Closed -$1.33M 64
2023
Q4
$1.33M Sell
16,100
-45,000
-74% -$3.43M 0.23% 54
2023
Q3
$4.79M Hold
61,100
0.93% 28
2023
Q2
$5.38M Hold
61,100
0.96% 27
2023
Q1
$4.93M Hold
61,100
0.96% 26
2022
Q4
$4.75M Hold
61,100
1.02% 25
2022
Q3
$4.93M Hold
61,100
1.07% 24
2022
Q2
$5.48M Hold
61,100
1.05% 26
2022
Q1
$6.78M Buy
61,100
+3,000
+5% +$317K 1.11% 23
2021
Q4
$6.01M Hold
58,100
0.95% 30
2021
Q3
$7.28M Buy
58,100
+14,000
+32% +$1.81M 1.14% 23
2021
Q2
$5.47M Buy
44,100
+8,000
+22% +$1M 0.91% 32
2021
Q1
$4.26M Buy
36,100
+3,000
+9% +$352K 0.94% 32
2020
Q4
$3.88M Buy
33,100
+4,000
+14% +$440K 1.01% 33
2020
Q3
$3.02M Hold
29,100
1.02% 32
2020
Q2
$2.67M Hold
29,100
1.01% 30
2020
Q1
$2.62M Buy
29,100
+7,500
+35% +$798K 1.16% 25
2019
Q4
$2.45M Hold
21,600
1.15% 27
2019
Q3
$2.35M Hold
21,600
1.21% 28
2019
Q2
$2.1M Sell
21,600
-20,000
-48% -$1.83M 1.1% 29
2019
Q1
$3.79M Hold
41,600
1.89% 21
2018
Q4
$3.78M Buy
41,600
+13,000
+45% +$1.21M 1.93% 21
2018
Q3
$2.42M Buy
28,600
+13,600
+91% +$1.26M 1.13% 31
2018
Q2
$1.28M Buy
+15,000
New +$1.25M 0.62% 41

Other funds holding MDT

Consolidated Investment Group's MDT Position: Q1 2024 in Review

Consolidated Investment Group sold out of Medtronic (MDT) in Q1 2024, closing a stake of 16,100 shares — an estimated $1.33M sold.

Consolidated Investment Group first reported a position in MDT in Q2 2018 and held it in 23 quarters. The position peaked at $7.28M in Q3 2021. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Consolidated Investment Group reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Consolidated Investment Group sold 16,100 Medtronic shares in Q1 2024, an estimated $1.33M.
  • Consolidated Investment Group first reported a position in Medtronic in Q2 2018 and held it in 23 quarters.
  • Consolidated Investment Group's Medtronic position peaked at $7.28M in Q3 2021.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Consolidated Investment Group's 13F filing for Q1 2024, filed 22 Apr 2024.